TTrialPathMatch Me to Trials
← Back to trials
RecruitingNonalcoholic Steatohepatitis

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

Eligible age

18+ yrs

Accepts

All genders

Locations

2 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Nonalcoholic Steatohepatitis (NASH) is a condition with increased amount of fat, inflammation and scarring in the liver. In compensated cirrhosis, the liver is coping with this damage and maintaining its important functions. Decompensation occurs when the liver becomes unable to perform all of its functions adequately. Variceal hemorrhage (bleeding from abnormal vessels in the liver called varices), Ascites (abnormal build-up of fluid in the abdomen), and Encephalopathy (brain confusion as a result of the liver not being able to get rid of toxic substances) are three symptoms of liver decompensation. The purpose of this research study is to investigate better ways to routinely monitor the condition of patients with NASH with compensated cirrhosis and to better pinpoint the development of decompensation in the livers of these patients.

Sponsor: Virginia Commonwealth University

You may qualify if…

  • ✓ Adult patients with presence of NAFLD associated cirrhosis.
  • ✓ Cirrhosis: biopsy confirmed or Agile F (F4) score \> 0.45
  • ✓ NAFLD as an etiology of liver disease will be determined based on presence of any of the following:
  • ✓ Biopsy showing \>5% steatosis or
  • ✓ CAP \> 280 dB/m or MR-PDFF\>5%
  • ✓ If CAP \< 280 dB/m or MR-PDFF \<5%, then must have type 2 diabetes and or 2 or more features of metabolic syndrome for 5 years (cryptogenic cirrhosis)

You may not qualify if…

  • ✕ Refusal to consent
  • ✕ Alcohol use \> 14/21 gm/week cutoff
  • ✕ Other causes of chronic liver disease
  • ✕ MELD \> 12
  • ✕ Hepatic and extrahepatic cancers expected to limit life expectancy \< 2 yrs
  • ✕ prior hepatic resections, TIPS, splenic embolization
  • ✕ prior decompensation events
  • ✕ inability to fit into MRI (failed hula-hoop test)

Where it's recruiting

Minnesota

Rochester

Virginia

Richmond

Source: ClinicalTrials.gov · NCT05720663 · last updated 2026-04-02

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibr · TrialPath